BioMarin lays off 120 employees to save $50M a year, with US operations hardest hit

When it comes to the current wave of layoffs, smaller biotechs have been disproportionately affected. But even some large drugmaker have been looking to lower their headcount, and now BioMarin is saying goodbye to 120 employees.